Skip to main navigation Skip to search Skip to main content

Cubist VAP - A Multi-Center, Open-Label, Randomized Study to Compare the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam with that of Piperacillin/Tazobactam in Ventilator Associated Pneumonia

Grants and Contracts Details

StatusFinished
Effective start/end date6/30/14 → 12/30/14

Funding

  • Inc Research Inc: $2,500.00